| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Melanoma | 83 | 2014 | 5317 | 5.630 |
Why?
|
| Receptor, PAR-1 | 12 | 2011 | 33 | 2.960 |
Why?
|
| Gene Expression Regulation, Neoplastic | 47 | 2013 | 8873 | 2.370 |
Why?
|
| Transcription Factor AP-2 | 22 | 2012 | 79 | 2.340 |
Why?
|
| Neoplasm Metastasis | 50 | 2013 | 5112 | 2.060 |
Why?
|
| Interleukin-8 | 18 | 2012 | 519 | 2.000 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 12 | 2012 | 194 | 2.000 |
Why?
|
| Neural Cell Adhesion Molecules | 12 | 2005 | 55 | 1.830 |
Why?
|
| Transcription Factors | 25 | 2013 | 5270 | 1.640 |
Why?
|
| Neovascularization, Pathologic | 27 | 2014 | 1547 | 1.610 |
Why?
|
| Mice, Nude | 55 | 2013 | 4307 | 1.410 |
Why?
|
| CD146 Antigen | 19 | 2011 | 57 | 1.340 |
Why?
|
| Antigens, CD | 13 | 2008 | 1385 | 1.320 |
Why?
|
| DNA-Binding Proteins | 21 | 2005 | 4821 | 1.320 |
Why?
|
| Matrix Metalloproteinase 2 | 15 | 2009 | 256 | 1.300 |
Why?
|
| Skin Neoplasms | 18 | 2014 | 4654 | 1.250 |
Why?
|
| Membrane Glycoproteins | 13 | 2003 | 1073 | 1.090 |
Why?
|
| Urinary Bladder Neoplasms | 18 | 2010 | 2341 | 0.980 |
Why?
|
| ErbB Receptors | 12 | 2011 | 2295 | 0.980 |
Why?
|
| Galectin 3 | 3 | 2012 | 138 | 0.960 |
Why?
|
| Transfection | 35 | 2012 | 2944 | 0.910 |
Why?
|
| Neoplasm Transplantation | 26 | 2013 | 1519 | 0.910 |
Why?
|
| Disease Progression | 26 | 2012 | 6682 | 0.880 |
Why?
|
| Mice | 92 | 2015 | 34495 | 0.850 |
Why?
|
| Animals | 113 | 2015 | 59536 | 0.840 |
Why?
|
| Cell Line, Tumor | 51 | 2015 | 14551 | 0.820 |
Why?
|
| Mice, Inbred BALB C | 27 | 2014 | 2314 | 0.800 |
Why?
|
| RNA, Small Interfering | 14 | 2013 | 2216 | 0.760 |
Why?
|
| Tumor Cells, Cultured | 39 | 2009 | 5395 | 0.750 |
Why?
|
| Gene Silencing | 9 | 2013 | 837 | 0.750 |
Why?
|
| Cell Division | 17 | 2008 | 2489 | 0.750 |
Why?
|
| Platelet Membrane Glycoproteins | 3 | 2009 | 70 | 0.730 |
Why?
|
| Receptors, G-Protein-Coupled | 5 | 2010 | 488 | 0.720 |
Why?
|
| Transcription, Genetic | 17 | 2010 | 3154 | 0.710 |
Why?
|
| Up-Regulation | 16 | 2013 | 2450 | 0.690 |
Why?
|
| Neoplasm Proteins | 10 | 2011 | 3230 | 0.670 |
Why?
|
| Cadherins | 5 | 2010 | 660 | 0.660 |
Why?
|
| Cell Adhesion | 10 | 2014 | 1008 | 0.660 |
Why?
|
| Platelet Activating Factor | 3 | 2009 | 55 | 0.660 |
Why?
|
| Matrix Metalloproteinase 9 | 9 | 2007 | 360 | 0.630 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 2 | 2010 | 153 | 0.590 |
Why?
|
| Neoplasm Invasiveness | 16 | 2013 | 3981 | 0.580 |
Why?
|
| Cell Adhesion Molecules | 4 | 2010 | 577 | 0.580 |
Why?
|
| Antineoplastic Agents | 22 | 2015 | 14289 | 0.580 |
Why?
|
| Antibodies, Monoclonal | 9 | 2010 | 4367 | 0.580 |
Why?
|
| Genes, Tumor Suppressor | 2 | 2010 | 1064 | 0.550 |
Why?
|
| Humans | 158 | 2015 | 261506 | 0.550 |
Why?
|
| Apoptosis | 21 | 2015 | 7591 | 0.540 |
Why?
|
| Down-Regulation | 12 | 2013 | 2074 | 0.530 |
Why?
|
| Proto-Oncogene Proteins c-kit | 8 | 2005 | 479 | 0.510 |
Why?
|
| Quinazolines | 5 | 2011 | 923 | 0.490 |
Why?
|
| Blotting, Western | 14 | 2010 | 3536 | 0.480 |
Why?
|
| Immunoglobulin Variable Region | 3 | 2004 | 173 | 0.470 |
Why?
|
| Dacarbazine | 3 | 2008 | 485 | 0.470 |
Why?
|
| Connexin 43 | 2 | 2013 | 46 | 0.470 |
Why?
|
| Activating Transcription Factor 1 | 8 | 2012 | 21 | 0.460 |
Why?
|
| Drug Resistance, Neoplasm | 12 | 2015 | 5178 | 0.460 |
Why?
|
| Tumor Microenvironment | 5 | 2014 | 2864 | 0.460 |
Why?
|
| Nodal Protein | 1 | 2012 | 21 | 0.430 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 2012 | 103 | 0.430 |
Why?
|
| Endoribonucleases | 3 | 2008 | 107 | 0.430 |
Why?
|
| Promoter Regions, Genetic | 16 | 2010 | 3101 | 0.420 |
Why?
|
| NFATC Transcription Factors | 1 | 2012 | 96 | 0.420 |
Why?
|
| Caspases | 4 | 2007 | 661 | 0.420 |
Why?
|
| Galectins | 1 | 2012 | 71 | 0.420 |
Why?
|
| Vascular Endothelial Growth Factor A | 11 | 2008 | 1533 | 0.410 |
Why?
|
| Matrix Metalloproteinase Inhibitors | 4 | 2007 | 57 | 0.410 |
Why?
|
| Thrombin | 2 | 2011 | 99 | 0.410 |
Why?
|
| Transplantation, Heterologous | 11 | 2010 | 1082 | 0.410 |
Why?
|
| Inhibitor of Differentiation Protein 1 | 1 | 2011 | 16 | 0.400 |
Why?
|
| Choroid Neoplasms | 1 | 2011 | 41 | 0.400 |
Why?
|
| Activating Transcription Factor 3 | 1 | 2011 | 31 | 0.400 |
Why?
|
| Melanocytes | 3 | 2007 | 219 | 0.390 |
Why?
|
| Cell Biology | 1 | 2010 | 16 | 0.390 |
Why?
|
| Immunoglobulin Fragments | 2 | 2001 | 28 | 0.390 |
Why?
|
| Receptor Cross-Talk | 1 | 2010 | 79 | 0.380 |
Why?
|
| Serpins | 1 | 2010 | 77 | 0.380 |
Why?
|
| NF-kappa B | 8 | 2012 | 1549 | 0.360 |
Why?
|
| Cysteine-Rich Protein 61 | 1 | 2009 | 8 | 0.360 |
Why?
|
| Antigens, Neoplasm | 3 | 2013 | 1506 | 0.340 |
Why?
|
| Cell Proliferation | 13 | 2013 | 7226 | 0.340 |
Why?
|
| Cysteine Endopeptidases | 4 | 2004 | 251 | 0.340 |
Why?
|
| Gene Expression Regulation | 8 | 2011 | 4053 | 0.330 |
Why?
|
| Antigens, Surface | 4 | 2003 | 295 | 0.330 |
Why?
|
| Colonic Neoplasms | 5 | 2008 | 1390 | 0.330 |
Why?
|
| Lung Neoplasms | 20 | 2012 | 11538 | 0.330 |
Why?
|
| Gene Expression Regulation, Enzymologic | 4 | 2009 | 703 | 0.330 |
Why?
|
| Phosphorylation | 15 | 2015 | 4804 | 0.320 |
Why?
|
| Inflammation | 2 | 2009 | 2522 | 0.320 |
Why?
|
| Enzyme Inhibitors | 8 | 2008 | 1879 | 0.320 |
Why?
|
| Proto-Oncogene Proteins c-fyn | 1 | 2008 | 31 | 0.320 |
Why?
|
| RNA, Messenger | 16 | 2012 | 6150 | 0.300 |
Why?
|
| Protein Kinase Inhibitors | 4 | 2015 | 4757 | 0.300 |
Why?
|
| Ribonuclease, Pancreatic | 1 | 2007 | 53 | 0.300 |
Why?
|
| Biomarkers, Tumor | 7 | 2012 | 10331 | 0.290 |
Why?
|
| Gene Expression Profiling | 8 | 2013 | 5159 | 0.290 |
Why?
|
| Base Sequence | 16 | 2008 | 4917 | 0.290 |
Why?
|
| RNA Interference | 6 | 2013 | 1408 | 0.290 |
Why?
|
| Sunlight | 1 | 2006 | 79 | 0.290 |
Why?
|
| Receptors, Thrombin | 2 | 2003 | 23 | 0.290 |
Why?
|
| Genes, p53 | 4 | 1995 | 1090 | 0.280 |
Why?
|
| DNA, Neoplasm | 8 | 2008 | 1910 | 0.270 |
Why?
|
| Vaccines, DNA | 1 | 2006 | 105 | 0.270 |
Why?
|
| RNA, Neoplasm | 4 | 2007 | 771 | 0.270 |
Why?
|
| MicroRNAs | 5 | 2013 | 2947 | 0.270 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 11 | 2010 | 3639 | 0.260 |
Why?
|
| Endothelial Cells | 6 | 2012 | 1048 | 0.260 |
Why?
|
| Carcinoma, Transitional Cell | 7 | 2008 | 962 | 0.260 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 6 | 2010 | 528 | 0.260 |
Why?
|
| Interleukin-10 | 2 | 1999 | 478 | 0.260 |
Why?
|
| Hedgehog Proteins | 1 | 2007 | 424 | 0.260 |
Why?
|
| Endothelium, Vascular | 3 | 2004 | 891 | 0.250 |
Why?
|
| Melanoma, Experimental | 2 | 2011 | 368 | 0.250 |
Why?
|
| Brain Neoplasms | 3 | 2014 | 4849 | 0.250 |
Why?
|
| Caspase Inhibitors | 2 | 2007 | 95 | 0.250 |
Why?
|
| Laminin | 6 | 2003 | 194 | 0.250 |
Why?
|
| Genes, Dominant | 2 | 2004 | 331 | 0.240 |
Why?
|
| Multienzyme Complexes | 2 | 2004 | 213 | 0.240 |
Why?
|
| Familial Mediterranean Fever | 5 | 1982 | 8 | 0.240 |
Why?
|
| Piperazines | 4 | 2008 | 2101 | 0.240 |
Why?
|
| Osteosarcoma | 3 | 2003 | 929 | 0.240 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 2004 | 80 | 0.240 |
Why?
|
| Sp1 Transcription Factor | 4 | 2006 | 188 | 0.240 |
Why?
|
| Gelatinases | 3 | 1999 | 52 | 0.240 |
Why?
|
| Tumor Necrosis Factor-alpha | 4 | 2003 | 1538 | 0.240 |
Why?
|
| Models, Biological | 8 | 2012 | 3254 | 0.230 |
Why?
|
| Antibodies, Neoplasm | 1 | 2004 | 259 | 0.230 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2003 | 94 | 0.230 |
Why?
|
| Point Mutation | 1 | 2006 | 769 | 0.230 |
Why?
|
| Protein-Tyrosine Kinases | 3 | 2006 | 1756 | 0.230 |
Why?
|
| Phenotype | 11 | 2014 | 6295 | 0.230 |
Why?
|
| Metalloendopeptidases | 3 | 1999 | 170 | 0.220 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2004 | 134 | 0.220 |
Why?
|
| Platelet-Derived Growth Factor | 2 | 2002 | 157 | 0.220 |
Why?
|
| Phenylalanine | 1 | 2003 | 142 | 0.220 |
Why?
|
| Pyrimidines | 5 | 2008 | 3518 | 0.220 |
Why?
|
| Cyclin E | 1 | 2005 | 267 | 0.220 |
Why?
|
| Genetic Therapy | 2 | 2010 | 1616 | 0.220 |
Why?
|
| DNA Mutational Analysis | 5 | 2008 | 2283 | 0.220 |
Why?
|
| Fusion Proteins, bcr-abl | 1 | 2008 | 1094 | 0.210 |
Why?
|
| Immunohistochemistry | 10 | 2010 | 7548 | 0.210 |
Why?
|
| Connexins | 2 | 2013 | 78 | 0.200 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 5 | 2009 | 2508 | 0.200 |
Why?
|
| Proteoglycans | 5 | 2003 | 259 | 0.200 |
Why?
|
| Monocytes | 6 | 2014 | 788 | 0.200 |
Why?
|
| Immunotherapy | 4 | 2008 | 3341 | 0.200 |
Why?
|
| Cell Movement | 7 | 2014 | 2466 | 0.200 |
Why?
|
| Activating Transcription Factor 2 | 2 | 2012 | 20 | 0.200 |
Why?
|
| Xenograft Model Antitumor Assays | 7 | 2015 | 3821 | 0.190 |
Why?
|
| Oligopeptides | 1 | 2003 | 429 | 0.190 |
Why?
|
| Breast Neoplasms | 8 | 2012 | 15694 | 0.190 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 5 | 2004 | 118 | 0.190 |
Why?
|
| Enzyme Activation | 6 | 2013 | 1764 | 0.190 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2004 | 630 | 0.190 |
Why?
|
| Liposomes | 4 | 2013 | 684 | 0.190 |
Why?
|
| Tissue Array Analysis | 3 | 2007 | 760 | 0.190 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2004 | 588 | 0.190 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 2 | 2015 | 272 | 0.190 |
Why?
|
| Prostatic Neoplasms | 4 | 2015 | 5767 | 0.190 |
Why?
|
| Drug Combinations | 5 | 2003 | 621 | 0.190 |
Why?
|
| Ribonuclease III | 3 | 2013 | 182 | 0.190 |
Why?
|
| Codon | 5 | 1993 | 241 | 0.190 |
Why?
|
| Genes, ras | 5 | 1990 | 667 | 0.190 |
Why?
|
| Signal Transduction | 12 | 2015 | 11965 | 0.190 |
Why?
|
| Stem Cell Factor | 2 | 1998 | 87 | 0.190 |
Why?
|
| Ovarian Neoplasms | 6 | 2013 | 4638 | 0.180 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 6 | 2008 | 2527 | 0.180 |
Why?
|
| Transcriptional Activation | 4 | 2010 | 1070 | 0.180 |
Why?
|
| Male | 46 | 2015 | 123000 | 0.180 |
Why?
|
| Genes, Reporter | 5 | 2004 | 798 | 0.180 |
Why?
|
| Macrophages | 8 | 1996 | 1304 | 0.170 |
Why?
|
| Phosphatidylinositol 3-Kinases | 3 | 2007 | 1678 | 0.170 |
Why?
|
| Time Factors | 9 | 2011 | 12926 | 0.170 |
Why?
|
| Antibodies | 2 | 2002 | 838 | 0.170 |
Why?
|
| Collagen | 5 | 2003 | 752 | 0.170 |
Why?
|
| Astrocytes | 2 | 2013 | 368 | 0.160 |
Why?
|
| Genetic Engineering | 2 | 1995 | 288 | 0.160 |
Why?
|
| MAP Kinase Signaling System | 5 | 2013 | 848 | 0.160 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 1998 | 167 | 0.160 |
Why?
|
| Fluorescent Antibody Technique | 3 | 2006 | 1062 | 0.160 |
Why?
|
| Cells, Cultured | 6 | 2012 | 5637 | 0.160 |
Why?
|
| Imatinib Mesylate | 4 | 2008 | 1665 | 0.160 |
Why?
|
| Exons | 5 | 2006 | 1328 | 0.160 |
Why?
|
| Cetuximab | 2 | 2010 | 472 | 0.150 |
Why?
|
| In Situ Nick-End Labeling | 5 | 2008 | 448 | 0.150 |
Why?
|
| Chemokine CCL2 | 2 | 1995 | 203 | 0.150 |
Why?
|
| Fibrosarcoma | 6 | 1989 | 135 | 0.150 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 8 | 2010 | 1489 | 0.150 |
Why?
|
| DNA Fragmentation | 4 | 2006 | 198 | 0.150 |
Why?
|
| Ultraviolet Rays | 2 | 1999 | 575 | 0.150 |
Why?
|
| Benzamides | 4 | 2008 | 1832 | 0.140 |
Why?
|
| Complement C3 | 2 | 1998 | 78 | 0.140 |
Why?
|
| Cathepsins | 4 | 2004 | 46 | 0.140 |
Why?
|
| Stromal Cells | 2 | 2011 | 825 | 0.140 |
Why?
|
| Pyridines | 4 | 2015 | 1244 | 0.140 |
Why?
|
| Blotting, Northern | 7 | 2003 | 682 | 0.140 |
Why?
|
| Neoplasms | 8 | 2014 | 15193 | 0.140 |
Why?
|
| Molecular Sequence Data | 10 | 2001 | 6089 | 0.140 |
Why?
|
| Cell Differentiation | 5 | 2004 | 4078 | 0.130 |
Why?
|
| RNA Editing | 2 | 2013 | 92 | 0.130 |
Why?
|
| Suppression, Genetic | 1 | 1995 | 67 | 0.130 |
Why?
|
| Integrins | 2 | 2010 | 262 | 0.130 |
Why?
|
| Organ Specificity | 2 | 2013 | 699 | 0.130 |
Why?
|
| Protein Binding | 5 | 2009 | 3438 | 0.130 |
Why?
|
| Chemotactic Factors | 1 | 1994 | 42 | 0.130 |
Why?
|
| Claudin-1 | 1 | 2014 | 32 | 0.130 |
Why?
|
| Female | 35 | 2013 | 141928 | 0.130 |
Why?
|
| Recombinant Proteins | 5 | 2007 | 2927 | 0.130 |
Why?
|
| Mutation | 14 | 2011 | 15179 | 0.120 |
Why?
|
| Endopeptidases | 1 | 1996 | 220 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-jun | 3 | 2010 | 166 | 0.120 |
Why?
|
| Tetrahydrofolate Dehydrogenase | 3 | 1983 | 28 | 0.120 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 2 | 2007 | 205 | 0.120 |
Why?
|
| Cell Communication | 4 | 2010 | 509 | 0.120 |
Why?
|
| Lymphatic Metastasis | 7 | 2012 | 4844 | 0.120 |
Why?
|
| Blast Crisis | 5 | 2008 | 557 | 0.120 |
Why?
|
| Cell Nucleus | 4 | 2005 | 1620 | 0.120 |
Why?
|
| Luciferases | 2 | 2007 | 445 | 0.120 |
Why?
|
| Mitogen-Activated Protein Kinases | 4 | 2005 | 639 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-akt | 5 | 2008 | 2054 | 0.120 |
Why?
|
| Amino Acid Sequence | 7 | 2003 | 4233 | 0.120 |
Why?
|
| Sulfonamides | 1 | 2003 | 1823 | 0.120 |
Why?
|
| Cytoplasm | 2 | 2006 | 652 | 0.120 |
Why?
|
| Neoplasms, Experimental | 3 | 2010 | 750 | 0.120 |
Why?
|
| Mice, SCID | 4 | 2013 | 1869 | 0.120 |
Why?
|
| Connexin 26 | 1 | 2013 | 21 | 0.120 |
Why?
|
| DNA | 8 | 2004 | 2693 | 0.110 |
Why?
|
| Glioma | 1 | 2005 | 1963 | 0.110 |
Why?
|
| Anilides | 1 | 2015 | 268 | 0.110 |
Why?
|
| Adenosine Deaminase | 1 | 2013 | 94 | 0.110 |
Why?
|
| Transformation, Genetic | 3 | 1983 | 57 | 0.110 |
Why?
|
| Phagocytosis | 10 | 1981 | 260 | 0.110 |
Why?
|
| Caspase 8 | 2 | 2003 | 145 | 0.110 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2013 | 132 | 0.110 |
Why?
|
| Microphthalmia-Associated Transcription Factor | 1 | 2012 | 42 | 0.110 |
Why?
|
| Caspase 6 | 2 | 2003 | 15 | 0.110 |
Why?
|
| Cell Growth Processes | 3 | 2009 | 342 | 0.110 |
Why?
|
| Frameshift Mutation | 1 | 1993 | 220 | 0.110 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 2013 | 97 | 0.110 |
Why?
|
| Neural Crest | 1 | 2013 | 85 | 0.110 |
Why?
|
| Caspase 9 | 2 | 2003 | 189 | 0.110 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 4 | 2007 | 476 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-fos | 2 | 2010 | 123 | 0.110 |
Why?
|
| Extracellular Matrix | 3 | 2008 | 554 | 0.110 |
Why?
|
| Chromatin | 2 | 2010 | 942 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2015 | 419 | 0.110 |
Why?
|
| Lymphangiogenesis | 1 | 2012 | 46 | 0.100 |
Why?
|
| Disease Models, Animal | 6 | 2015 | 7222 | 0.100 |
Why?
|
| Neutrophils | 6 | 1982 | 835 | 0.100 |
Why?
|
| Adenosine Triphosphatases | 2 | 2013 | 435 | 0.100 |
Why?
|
| H-2 Antigens | 5 | 1989 | 42 | 0.100 |
Why?
|
| Membrane Transport Proteins | 1 | 2013 | 244 | 0.100 |
Why?
|
| Neoplasms, Unknown Primary | 1 | 1993 | 192 | 0.100 |
Why?
|
| Lysophospholipids | 1 | 2012 | 147 | 0.100 |
Why?
|
| NIH 3T3 Cells | 2 | 2010 | 260 | 0.100 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2013 | 299 | 0.100 |
Why?
|
| Neuroglia | 1 | 2013 | 223 | 0.100 |
Why?
|
| DEAD-box RNA Helicases | 2 | 2013 | 255 | 0.100 |
Why?
|
| Carrier Proteins | 3 | 1997 | 2022 | 0.100 |
Why?
|
| Proto-Oncogene Protein c-ets-1 | 1 | 2010 | 36 | 0.100 |
Why?
|
| Proteins | 3 | 2013 | 1963 | 0.100 |
Why?
|
| Selectins | 1 | 2010 | 6 | 0.100 |
Why?
|
| Chitosan | 1 | 2011 | 79 | 0.100 |
Why?
|
| Molecular Targeted Therapy | 2 | 2011 | 2330 | 0.100 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 3 | 2008 | 460 | 0.090 |
Why?
|
| DNA Primers | 5 | 2008 | 1399 | 0.090 |
Why?
|
| Hydrogels | 1 | 2011 | 123 | 0.090 |
Why?
|
| Aspergillus niger | 2 | 2007 | 25 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2012 | 4938 | 0.090 |
Why?
|
| Blood Coagulation | 1 | 2011 | 185 | 0.090 |
Why?
|
| Gene Expression | 6 | 2009 | 3570 | 0.090 |
Why?
|
| Dimerization | 1 | 2010 | 304 | 0.090 |
Why?
|
| Collagenases | 4 | 2000 | 74 | 0.090 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 1994 | 661 | 0.090 |
Why?
|
| Tumor Suppressor Protein p53 | 5 | 2004 | 3552 | 0.090 |
Why?
|
| Polymerase Chain Reaction | 5 | 2007 | 3203 | 0.090 |
Why?
|
| Antibodies, Blocking | 2 | 2002 | 91 | 0.090 |
Why?
|
| src-Family Kinases | 1 | 2013 | 478 | 0.090 |
Why?
|
| Flow Cytometry | 3 | 2008 | 3033 | 0.090 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 1 | 2009 | 38 | 0.090 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2011 | 518 | 0.090 |
Why?
|
| Methotrexate | 4 | 1983 | 999 | 0.090 |
Why?
|
| Killer Cells, Natural | 6 | 1999 | 904 | 0.090 |
Why?
|
| Immunoglobulins | 1 | 2010 | 266 | 0.090 |
Why?
|
| CREB-Binding Protein | 1 | 2009 | 86 | 0.090 |
Why?
|
| Retinoblastoma Protein | 2 | 2008 | 335 | 0.090 |
Why?
|
| E2F1 Transcription Factor | 1 | 2010 | 206 | 0.090 |
Why?
|
| Bone Neoplasms | 3 | 2015 | 2576 | 0.090 |
Why?
|
| Calcium | 2 | 2010 | 1537 | 0.090 |
Why?
|
| Immunoglobulin G | 2 | 2003 | 1021 | 0.090 |
Why?
|
| Leukemia-Lymphoma, Adult T-Cell | 1 | 1989 | 65 | 0.080 |
Why?
|
| Interleukin-1 | 2 | 2003 | 461 | 0.080 |
Why?
|
| Tumor Suppressor Proteins | 3 | 2006 | 1823 | 0.080 |
Why?
|
| Nuclear Proteins | 5 | 2006 | 3343 | 0.080 |
Why?
|
| In Vitro Techniques | 7 | 2006 | 1618 | 0.080 |
Why?
|
| History, 21st Century | 1 | 2010 | 441 | 0.080 |
Why?
|
| Platelet Activation | 1 | 2009 | 116 | 0.080 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2008 | 45 | 0.080 |
Why?
|
| Chemotaxis, Leukocyte | 5 | 1981 | 157 | 0.080 |
Why?
|
| Keratinocytes | 1 | 2009 | 241 | 0.080 |
Why?
|
| Dihydropyridines | 1 | 2007 | 10 | 0.080 |
Why?
|
| Cell Line | 6 | 2008 | 5114 | 0.080 |
Why?
|
| History, 20th Century | 1 | 2010 | 574 | 0.080 |
Why?
|
| Matrix Metalloproteinase 14 | 1 | 2007 | 18 | 0.080 |
Why?
|
| Antibodies, Monoclonal, Humanized | 2 | 2010 | 3251 | 0.080 |
Why?
|
| Carcinogenicity Tests | 2 | 1998 | 70 | 0.080 |
Why?
|
| Pyrimethamine | 1 | 2007 | 4 | 0.080 |
Why?
|
| Organoselenium Compounds | 1 | 2007 | 6 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 2 | 2007 | 371 | 0.080 |
Why?
|
| Colchicine | 4 | 1982 | 52 | 0.080 |
Why?
|
| Microvessels | 1 | 2008 | 135 | 0.080 |
Why?
|
| Administration, Oral | 2 | 2011 | 1544 | 0.080 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 1989 | 182 | 0.080 |
Why?
|
| Chemokines | 1 | 2009 | 314 | 0.080 |
Why?
|
| CDC2-CDC28 Kinases | 2 | 2005 | 129 | 0.080 |
Why?
|
| Cell Cycle Proteins | 3 | 2005 | 2045 | 0.080 |
Why?
|
| Folic Acid Antagonists | 1 | 2007 | 45 | 0.080 |
Why?
|
| Vascular Endothelial Growth Factors | 4 | 2007 | 212 | 0.080 |
Why?
|
| Zinc Finger Protein GLI1 | 1 | 2007 | 111 | 0.080 |
Why?
|
| Molecular Weight | 3 | 2005 | 629 | 0.080 |
Why?
|
| K562 Cells | 1 | 2008 | 338 | 0.070 |
Why?
|
| Immune System | 1 | 2009 | 279 | 0.070 |
Why?
|
| Receptor, ErbB-3 | 1 | 2007 | 122 | 0.070 |
Why?
|
| Disease-Free Survival | 2 | 2011 | 10001 | 0.070 |
Why?
|
| Receptor, EphA2 | 1 | 2008 | 132 | 0.070 |
Why?
|
| Epithelium | 1 | 2009 | 720 | 0.070 |
Why?
|
| Carcinoma | 3 | 2013 | 2578 | 0.070 |
Why?
|
| Laser Scanning Cytometry | 1 | 2006 | 16 | 0.070 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2007 | 142 | 0.070 |
Why?
|
| Alphavirus | 1 | 2006 | 20 | 0.070 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2011 | 607 | 0.070 |
Why?
|
| Urothelium | 2 | 2008 | 254 | 0.070 |
Why?
|
| Drug Delivery Systems | 1 | 2011 | 669 | 0.070 |
Why?
|
| X-Linked Inhibitor of Apoptosis Protein | 1 | 2007 | 119 | 0.070 |
Why?
|
| Antigen-Antibody Complex | 3 | 1984 | 115 | 0.070 |
Why?
|
| Interleukins | 1 | 2009 | 325 | 0.070 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 1987 | 182 | 0.070 |
Why?
|
| Treatment Outcome | 6 | 2015 | 32848 | 0.070 |
Why?
|
| Oncogenes | 2 | 1987 | 673 | 0.070 |
Why?
|
| Dysplastic Nevus Syndrome | 1 | 2006 | 50 | 0.070 |
Why?
|
| Cyclin-Dependent Kinase 2 | 2 | 2005 | 249 | 0.070 |
Why?
|
| Benzenesulfonates | 1 | 2007 | 195 | 0.070 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 2 | 2005 | 104 | 0.070 |
Why?
|
| Binding Sites | 3 | 2013 | 2171 | 0.070 |
Why?
|
| Regulatory Factor X Transcription Factors | 1 | 2005 | 24 | 0.070 |
Why?
|
| Nevus, Pigmented | 1 | 2006 | 104 | 0.070 |
Why?
|
| Nevus | 1 | 2006 | 107 | 0.070 |
Why?
|
| Urea | 1 | 2007 | 290 | 0.070 |
Why?
|
| Transcription Factor AP-1 | 2 | 2004 | 246 | 0.070 |
Why?
|
| Cell Line, Transformed | 2 | 2005 | 394 | 0.070 |
Why?
|
| Cisplatin | 1 | 2013 | 2432 | 0.070 |
Why?
|
| Niacinamide | 1 | 2007 | 421 | 0.070 |
Why?
|
| Sequence Analysis, DNA | 1 | 1993 | 2483 | 0.070 |
Why?
|
| Shigella flexneri | 7 | 1980 | 15 | 0.070 |
Why?
|
| Drug Interactions | 1 | 2007 | 553 | 0.070 |
Why?
|
| Antigens | 2 | 1976 | 292 | 0.070 |
Why?
|
| Epithelial Cells | 4 | 2009 | 1818 | 0.070 |
Why?
|
| DNA, Complementary | 4 | 2004 | 869 | 0.060 |
Why?
|
| HLA Antigens | 1 | 1988 | 546 | 0.060 |
Why?
|
| Middle Aged | 18 | 2013 | 86204 | 0.060 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2008 | 560 | 0.060 |
Why?
|
| Plasmids | 2 | 2004 | 837 | 0.060 |
Why?
|
| Sensitivity and Specificity | 2 | 2010 | 4971 | 0.060 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2006 | 566 | 0.060 |
Why?
|
| Drug Synergism | 2 | 2007 | 1313 | 0.060 |
Why?
|
| Oligodendroglioma | 1 | 2005 | 106 | 0.060 |
Why?
|
| Aged, 80 and over | 6 | 2011 | 29902 | 0.060 |
Why?
|
| Cloning, Molecular | 2 | 2004 | 1213 | 0.060 |
Why?
|
| Chromosome Mapping | 1 | 2008 | 1471 | 0.060 |
Why?
|
| Structure-Activity Relationship | 1 | 2006 | 931 | 0.060 |
Why?
|
| Taxoids | 1 | 2008 | 967 | 0.060 |
Why?
|
| Psoriasis | 3 | 1979 | 126 | 0.060 |
Why?
|
| Cathepsin L | 3 | 2004 | 25 | 0.060 |
Why?
|
| Muramidase | 2 | 1981 | 110 | 0.060 |
Why?
|
| Chromones | 1 | 2004 | 120 | 0.060 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2008 | 519 | 0.060 |
Why?
|
| Pyrroles | 1 | 2008 | 576 | 0.060 |
Why?
|
| Amino Acid Motifs | 1 | 2005 | 392 | 0.060 |
Why?
|
| Carcinoma, Lewis Lung | 1 | 2004 | 35 | 0.060 |
Why?
|
| Adaptor Protein Complex 2 | 1 | 2003 | 2 | 0.060 |
Why?
|
| Antigens, Differentiation | 1 | 2005 | 238 | 0.060 |
Why?
|
| Anticarcinogenic Agents | 1 | 2006 | 362 | 0.060 |
Why?
|
| Phenylurea Compounds | 1 | 2007 | 580 | 0.060 |
Why?
|
| Reference Values | 2 | 2006 | 1099 | 0.060 |
Why?
|
| Nucleic Acid Hybridization | 2 | 2003 | 542 | 0.060 |
Why?
|
| Binding, Competitive | 1 | 2003 | 300 | 0.060 |
Why?
|
| Prognosis | 5 | 2008 | 21713 | 0.060 |
Why?
|
| Endothelial Growth Factors | 3 | 2000 | 197 | 0.060 |
Why?
|
| Stress, Psychological | 1 | 2010 | 1000 | 0.060 |
Why?
|
| Intracellular Membranes | 1 | 2003 | 108 | 0.060 |
Why?
|
| Sequence Deletion | 1 | 2006 | 875 | 0.060 |
Why?
|
| Androstadienes | 1 | 2004 | 165 | 0.060 |
Why?
|
| Lymphokines | 3 | 2000 | 272 | 0.060 |
Why?
|
| Protein Array Analysis | 1 | 2005 | 501 | 0.060 |
Why?
|
| Adult | 18 | 2011 | 77950 | 0.060 |
Why?
|
| Flavonoids | 1 | 2004 | 188 | 0.060 |
Why?
|
| Carcinoma, Renal Cell | 1 | 1995 | 2326 | 0.060 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2004 | 243 | 0.060 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2003 | 184 | 0.050 |
Why?
|
| Cell Death | 2 | 2004 | 671 | 0.050 |
Why?
|
| Ligands | 2 | 2003 | 995 | 0.050 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2003 | 215 | 0.050 |
Why?
|
| Genes | 4 | 1997 | 491 | 0.050 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2008 | 2232 | 0.050 |
Why?
|
| PTEN Phosphohydrolase | 2 | 2006 | 986 | 0.050 |
Why?
|
| Protein Isoforms | 1 | 2005 | 842 | 0.050 |
Why?
|
| Morpholines | 1 | 2004 | 289 | 0.050 |
Why?
|
| Astrocytoma | 1 | 2005 | 321 | 0.050 |
Why?
|
| T-Lymphocytes, Cytotoxic | 2 | 2006 | 1016 | 0.050 |
Why?
|
| Staphylococcus | 5 | 1980 | 86 | 0.050 |
Why?
|
| Neoplasm Staging | 3 | 2015 | 13658 | 0.050 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2004 | 589 | 0.050 |
Why?
|
| Boronic Acids | 1 | 2004 | 362 | 0.050 |
Why?
|
| Tibia | 1 | 2002 | 131 | 0.050 |
Why?
|
| Antibody Specificity | 1 | 2002 | 334 | 0.050 |
Why?
|
| Amino Acid Chloromethyl Ketones | 1 | 2001 | 25 | 0.050 |
Why?
|
| Membrane Potentials | 1 | 2003 | 424 | 0.050 |
Why?
|
| Spheroids, Cellular | 1 | 2002 | 222 | 0.050 |
Why?
|
| Aged | 11 | 2011 | 70117 | 0.050 |
Why?
|
| Lymphocyte Activation | 1 | 2006 | 1688 | 0.050 |
Why?
|
| Cell Lineage | 2 | 2014 | 668 | 0.050 |
Why?
|
| Kidney Neoplasms | 1 | 1995 | 3022 | 0.050 |
Why?
|
| Microtubules | 1 | 1982 | 270 | 0.050 |
Why?
|
| Receptor, ErbB-2 | 2 | 2008 | 2518 | 0.050 |
Why?
|
| Cyclins | 2 | 2004 | 456 | 0.050 |
Why?
|
| Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2001 | 157 | 0.050 |
Why?
|
| Pyrazines | 1 | 2004 | 495 | 0.050 |
Why?
|
| In Situ Hybridization | 3 | 2003 | 1037 | 0.050 |
Why?
|
| Isoenzymes | 1 | 2003 | 614 | 0.050 |
Why?
|
| Norepinephrine | 2 | 2013 | 272 | 0.050 |
Why?
|
| Epitopes | 3 | 1996 | 685 | 0.050 |
Why?
|
| Keratins | 1 | 2001 | 330 | 0.050 |
Why?
|
| Hot Temperature | 1 | 1981 | 281 | 0.050 |
Why?
|
| Prostatic Hyperplasia | 1 | 2001 | 210 | 0.050 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2001 | 154 | 0.050 |
Why?
|
| Culture Media | 1 | 2001 | 319 | 0.050 |
Why?
|
| Luminescent Proteins | 1 | 2001 | 289 | 0.050 |
Why?
|
| Texas | 1 | 2011 | 6311 | 0.050 |
Why?
|
| Bone and Bones | 1 | 2003 | 619 | 0.050 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2001 | 611 | 0.050 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2002 | 330 | 0.050 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2003 | 621 | 0.050 |
Why?
|
| Blotting, Southern | 4 | 1993 | 406 | 0.050 |
Why?
|
| Trans-Activators | 1 | 2006 | 1555 | 0.050 |
Why?
|
| Adenocarcinoma | 3 | 1994 | 7789 | 0.050 |
Why?
|
| Proportional Hazards Models | 2 | 2008 | 4988 | 0.040 |
Why?
|
| Depression, Chemical | 1 | 1999 | 52 | 0.040 |
Why?
|
| Sirolimus | 1 | 2004 | 814 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 3 | 2007 | 15862 | 0.040 |
Why?
|
| Green Fluorescent Proteins | 1 | 2001 | 694 | 0.040 |
Why?
|
| Phagocytes | 1 | 1979 | 44 | 0.040 |
Why?
|
| Mice, Inbred NOD | 2 | 2013 | 905 | 0.040 |
Why?
|
| Proto-Oncogenes | 3 | 1988 | 202 | 0.040 |
Why?
|
| Thapsigargin | 1 | 1998 | 38 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 2 | 2006 | 6942 | 0.040 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 1999 | 106 | 0.040 |
Why?
|
| Calcium-Transporting ATPases | 1 | 1998 | 60 | 0.040 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2006 | 1248 | 0.040 |
Why?
|
| Enzyme Precursors | 1 | 1998 | 66 | 0.040 |
Why?
|
| Deoxycytidine | 1 | 2004 | 1353 | 0.040 |
Why?
|
| Cytotoxicity, Immunologic | 4 | 1994 | 675 | 0.040 |
Why?
|
| Bone Marrow | 2 | 1983 | 2358 | 0.040 |
Why?
|
| Alternative Splicing | 1 | 2001 | 584 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 2 | 2009 | 259 | 0.040 |
Why?
|
| Cell Hypoxia | 1 | 1999 | 328 | 0.040 |
Why?
|
| Prostate-Specific Antigen | 1 | 2001 | 993 | 0.040 |
Why?
|
| Peptides | 2 | 2001 | 1479 | 0.040 |
Why?
|
| Tumor Burden | 2 | 2015 | 1987 | 0.040 |
Why?
|
| Clinical Trials as Topic | 1 | 2007 | 3719 | 0.040 |
Why?
|
| Prostatectomy | 1 | 2001 | 962 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2005 | 4892 | 0.040 |
Why?
|
| Antigens, Bacterial | 2 | 1976 | 354 | 0.040 |
Why?
|
| Immunoblotting | 3 | 2008 | 886 | 0.040 |
Why?
|
| Membrane Proteins | 2 | 2004 | 2819 | 0.040 |
Why?
|
| Myelodysplastic Syndromes | 2 | 1991 | 2979 | 0.040 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2000 | 1555 | 0.040 |
Why?
|
| Kisspeptins | 2 | 2006 | 15 | 0.040 |
Why?
|
| Lipopolysaccharides | 2 | 1994 | 558 | 0.040 |
Why?
|
| Adolescent | 10 | 2005 | 31252 | 0.040 |
Why?
|
| Rats | 4 | 2006 | 6086 | 0.030 |
Why?
|
| Prostate | 1 | 2001 | 1088 | 0.030 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 1999 | 388 | 0.030 |
Why?
|
| Mesoderm | 2 | 2009 | 404 | 0.030 |
Why?
|
| Mitochondria | 1 | 2003 | 1282 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 2 | 2008 | 1165 | 0.030 |
Why?
|
| Lymph Nodes | 1 | 2006 | 2967 | 0.030 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2005 | 2359 | 0.030 |
Why?
|
| Cycloheximide | 1 | 1995 | 97 | 0.030 |
Why?
|
| Transplantation, Isogeneic | 1 | 1995 | 56 | 0.030 |
Why?
|
| Arthritis, Rheumatoid | 1 | 1980 | 410 | 0.030 |
Why?
|
| Proto-Oncogene Proteins | 4 | 2005 | 2488 | 0.030 |
Why?
|
| Paclitaxel | 1 | 2002 | 1996 | 0.030 |
Why?
|
| DNA Repair Enzymes | 1 | 1997 | 237 | 0.030 |
Why?
|
| Hematopoietic Stem Cells | 1 | 1982 | 1242 | 0.030 |
Why?
|
| Models, Molecular | 2 | 2013 | 1732 | 0.030 |
Why?
|
| Cell Transplantation | 1 | 1995 | 85 | 0.030 |
Why?
|
| Gene Amplification | 2 | 1989 | 731 | 0.030 |
Why?
|
| Invertebrates | 1 | 1985 | 9 | 0.030 |
Why?
|
| Receptors, Cell Surface | 2 | 1997 | 862 | 0.030 |
Why?
|
| 3T3 Cells | 1 | 1995 | 355 | 0.030 |
Why?
|
| Macrophage Activation | 1 | 1995 | 148 | 0.030 |
Why?
|
| Receptors, Colony-Stimulating Factor | 1 | 1994 | 12 | 0.030 |
Why?
|
| Vertebrates | 1 | 1985 | 68 | 0.030 |
Why?
|
| Skin | 3 | 1999 | 1259 | 0.030 |
Why?
|
| Neoplasm Micrometastasis | 1 | 2014 | 49 | 0.030 |
Why?
|
| Receptors, Interferon | 1 | 1994 | 44 | 0.030 |
Why?
|
| Caseins | 1 | 2004 | 63 | 0.030 |
Why?
|
| MART-1 Antigen | 1 | 2004 | 105 | 0.030 |
Why?
|
| Cyclic AMP | 3 | 2013 | 358 | 0.030 |
Why?
|
| Genetic Markers | 2 | 2006 | 974 | 0.030 |
Why?
|
| Monophenol Monooxygenase | 1 | 2004 | 59 | 0.030 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2015 | 182 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2004 | 5710 | 0.030 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 1995 | 726 | 0.030 |
Why?
|
| Cytokines | 1 | 2003 | 2809 | 0.030 |
Why?
|
| Multicenter Studies as Topic | 1 | 2015 | 543 | 0.030 |
Why?
|
| Analysis of Variance | 2 | 2008 | 2307 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2006 | 9244 | 0.030 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 1993 | 70 | 0.030 |
Why?
|
| R-SNARE Proteins | 1 | 2013 | 18 | 0.030 |
Why?
|
| Sequence Alignment | 1 | 1995 | 844 | 0.030 |
Why?
|
| Biological Evolution | 1 | 1985 | 278 | 0.030 |
Why?
|
| Qa-SNARE Proteins | 1 | 2013 | 37 | 0.030 |
Why?
|
| Pregnancy Proteins | 1 | 2013 | 44 | 0.030 |
Why?
|
| Positron-Emission Tomography | 2 | 2015 | 2173 | 0.030 |
Why?
|
| Homozygote | 1 | 1995 | 717 | 0.030 |
Why?
|
| United States | 1 | 2010 | 15433 | 0.030 |
Why?
|
| Sarcoma | 1 | 2003 | 1725 | 0.030 |
Why?
|
| Erythrocyte Membrane | 1 | 1992 | 36 | 0.030 |
Why?
|
| Hep G2 Cells | 1 | 2013 | 155 | 0.030 |
Why?
|
| Rh-Hr Blood-Group System | 1 | 1992 | 24 | 0.030 |
Why?
|
| Phosphoserine | 1 | 2013 | 107 | 0.030 |
Why?
|
| Genetic Heterogeneity | 1 | 1994 | 318 | 0.030 |
Why?
|
| Young Adult | 1 | 2011 | 21445 | 0.030 |
Why?
|
| HCT116 Cells | 1 | 2013 | 348 | 0.030 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 2015 | 665 | 0.030 |
Why?
|
| Golgi Apparatus | 1 | 2013 | 147 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2015 | 1077 | 0.030 |
Why?
|
| Leukemia | 2 | 1991 | 1635 | 0.030 |
Why?
|
| Receptors, Lysophosphatidic Acid | 1 | 2012 | 80 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 1998 | 1493 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 1996 | 1038 | 0.030 |
Why?
|
| Lysosomes | 4 | 1981 | 347 | 0.030 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2013 | 234 | 0.030 |
Why?
|
| Genes, Retinoblastoma | 1 | 1991 | 86 | 0.030 |
Why?
|
| Blood Bactericidal Activity | 3 | 1981 | 18 | 0.030 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 1996 | 992 | 0.030 |
Why?
|
| Cell Membrane | 2 | 2013 | 850 | 0.020 |
Why?
|
| Tyrosine | 1 | 2013 | 498 | 0.020 |
Why?
|
| Brain | 1 | 2005 | 4113 | 0.020 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2013 | 347 | 0.020 |
Why?
|
| Methylcholanthrene | 2 | 1989 | 29 | 0.020 |
Why?
|
| Intracellular Fluid | 1 | 2010 | 45 | 0.020 |
Why?
|
| Lymphatic Vessels | 1 | 2012 | 143 | 0.020 |
Why?
|
| Fluorescent Dyes | 1 | 2013 | 459 | 0.020 |
Why?
|
| Colorectal Neoplasms | 1 | 2006 | 3578 | 0.020 |
Why?
|
| Aging | 1 | 1979 | 1582 | 0.020 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2013 | 323 | 0.020 |
Why?
|
| Immunosorbent Techniques | 2 | 1987 | 57 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 1998 | 1664 | 0.020 |
Why?
|
| Gene Deletion | 1 | 1995 | 1442 | 0.020 |
Why?
|
| Restraint, Physical | 1 | 2010 | 50 | 0.020 |
Why?
|
| Protein Kinases | 2 | 2005 | 874 | 0.020 |
Why?
|
| Lipids | 1 | 2004 | 644 | 0.020 |
Why?
|
| Colony-Forming Units Assay | 2 | 1981 | 249 | 0.020 |
Why?
|
| Interferon-alpha | 1 | 1994 | 889 | 0.020 |
Why?
|
| Antibody-Dependent Cell Cytotoxicity | 2 | 1980 | 84 | 0.020 |
Why?
|
| Vasoconstrictor Agents | 1 | 2010 | 151 | 0.020 |
Why?
|
| Fibroblast Growth Factor 2 | 2 | 2000 | 223 | 0.020 |
Why?
|
| Acid Phosphatase | 2 | 1981 | 59 | 0.020 |
Why?
|
| Stress, Physiological | 1 | 2013 | 492 | 0.020 |
Why?
|
| Glucuronidase | 2 | 1981 | 48 | 0.020 |
Why?
|
| Anemia, Refractory, with Excess of Blasts | 1 | 1989 | 86 | 0.020 |
Why?
|
| Histocompatibility Antigens | 1 | 1989 | 74 | 0.020 |
Why?
|
| Cell Dedifferentiation | 1 | 2009 | 96 | 0.020 |
Why?
|
| DNA Repair | 1 | 1997 | 1872 | 0.020 |
Why?
|
| Hematologic Diseases | 1 | 1990 | 242 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2010 | 503 | 0.020 |
Why?
|
| Child | 5 | 2005 | 29154 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2008 | 6207 | 0.020 |
Why?
|
| Fibroblasts | 1 | 1995 | 1682 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2005 | 16273 | 0.020 |
Why?
|
| Cecum | 1 | 2008 | 42 | 0.020 |
Why?
|
| DNA Restriction Enzymes | 1 | 1988 | 117 | 0.020 |
Why?
|
| Receptor, ErbB-4 | 1 | 2007 | 23 | 0.020 |
Why?
|
| Transforming Growth Factor alpha | 1 | 2008 | 95 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2009 | 280 | 0.020 |
Why?
|
| Genes, MHC Class I | 1 | 1988 | 46 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 13 | 1 | 2008 | 141 | 0.020 |
Why?
|
| Topoisomerase I Inhibitors | 1 | 2008 | 75 | 0.020 |
Why?
|
| Receptors, Purinergic P2 | 1 | 2007 | 28 | 0.020 |
Why?
|
| Kirsten murine sarcoma virus | 1 | 1987 | 5 | 0.020 |
Why?
|
| Matrix Metalloproteinases | 1 | 2008 | 143 | 0.020 |
Why?
|
| beta 2-Microglobulin | 1 | 1988 | 184 | 0.020 |
Why?
|
| DNA Damage | 1 | 1995 | 1954 | 0.020 |
Why?
|
| Microcirculation | 1 | 2008 | 200 | 0.020 |
Why?
|
| Sarcoma, Experimental | 1 | 1987 | 68 | 0.020 |
Why?
|
| RNA-Binding Proteins | 1 | 2013 | 984 | 0.020 |
Why?
|
| raf Kinases | 1 | 2007 | 81 | 0.020 |
Why?
|
| Mice, Inbred C3H | 1 | 1987 | 385 | 0.020 |
Why?
|
| Necrosis | 1 | 2008 | 580 | 0.020 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2006 | 191 | 0.020 |
Why?
|
| Mediator Complex | 1 | 2006 | 69 | 0.020 |
Why?
|
| Mice, Inbred CBA | 2 | 1983 | 78 | 0.020 |
Why?
|
| Ribonucleases | 1 | 2006 | 88 | 0.020 |
Why?
|
| Microsatellite Repeats | 1 | 2008 | 575 | 0.020 |
Why?
|
| S Phase | 1 | 2007 | 281 | 0.020 |
Why?
|
| G1 Phase | 1 | 2007 | 285 | 0.020 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2013 | 1283 | 0.020 |
Why?
|
| Consensus Sequence | 1 | 2005 | 117 | 0.020 |
Why?
|
| Clone Cells | 1 | 1987 | 555 | 0.020 |
Why?
|
| Loss of Heterozygosity | 1 | 2007 | 602 | 0.020 |
Why?
|
| Enzyme Induction | 1 | 2005 | 249 | 0.020 |
Why?
|
| Cell Survival | 1 | 2012 | 3045 | 0.020 |
Why?
|
| Camptothecin | 1 | 2008 | 517 | 0.020 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2005 | 163 | 0.020 |
Why?
|
| Genes, Regulator | 1 | 2005 | 69 | 0.020 |
Why?
|
| Urinary Bladder | 1 | 2008 | 575 | 0.020 |
Why?
|
| Viral Proteins | 2 | 1985 | 435 | 0.020 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2005 | 161 | 0.020 |
Why?
|
| Micronuclei, Chromosome-Defective | 1 | 2005 | 34 | 0.020 |
Why?
|
| Lymphoma | 2 | 1991 | 1467 | 0.020 |
Why?
|
| Sentinel Lymph Node Biopsy | 1 | 2012 | 1415 | 0.020 |
Why?
|
| Centrosome | 1 | 2005 | 95 | 0.020 |
Why?
|
| Aurora Kinases | 1 | 2005 | 189 | 0.020 |
Why?
|
| Transcriptome | 1 | 2013 | 1859 | 0.020 |
Why?
|
| Probability | 1 | 2006 | 866 | 0.020 |
Why?
|
| Xenopus Proteins | 1 | 2005 | 185 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2007 | 1487 | 0.010 |
Why?
|
| Aurora Kinase A | 1 | 2005 | 202 | 0.010 |
Why?
|
| NF-KappaB Inhibitor alpha | 1 | 2003 | 136 | 0.010 |
Why?
|
| Cyclin D1 | 1 | 2005 | 576 | 0.010 |
Why?
|
| Molecular Biology | 1 | 2004 | 176 | 0.010 |
Why?
|
| Mutation, Missense | 1 | 2008 | 1152 | 0.010 |
Why?
|
| Lung | 1 | 1994 | 3151 | 0.010 |
Why?
|
| DNA Methylation | 1 | 2013 | 2669 | 0.010 |
Why?
|
| I-kappa B Proteins | 1 | 2003 | 170 | 0.010 |
Why?
|
| Concanavalin A | 1 | 1982 | 67 | 0.010 |
Why?
|
| ras Proteins | 1 | 2007 | 770 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2010 | 4143 | 0.010 |
Why?
|
| Chloramphenicol | 1 | 2002 | 28 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2008 | 2315 | 0.010 |
Why?
|
| Thymidine Kinase | 1 | 1982 | 193 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2003 | 585 | 0.010 |
Why?
|
| Tubulin | 1 | 1982 | 169 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 2002 | 80 | 0.010 |
Why?
|
| Cell Fractionation | 1 | 1982 | 68 | 0.010 |
Why?
|
| Microinjections | 1 | 1982 | 96 | 0.010 |
Why?
|
| Bortezomib | 1 | 2004 | 543 | 0.010 |
Why?
|
| Biopsy, Needle | 1 | 2006 | 1363 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2007 | 1450 | 0.010 |
Why?
|
| Genomic Instability | 1 | 2005 | 519 | 0.010 |
Why?
|
| Phorbols | 1 | 1981 | 9 | 0.010 |
Why?
|
| Drug Resistance, Microbial | 1 | 1982 | 218 | 0.010 |
Why?
|
| Glutamate Dehydrogenase | 1 | 1981 | 14 | 0.010 |
Why?
|
| Phorbol Esters | 1 | 1981 | 39 | 0.010 |
Why?
|
| Drug Resistance | 1 | 1983 | 587 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2013 | 9180 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2008 | 4298 | 0.010 |
Why?
|
| Chromosomes | 1 | 1982 | 244 | 0.010 |
Why?
|
| Pyruvate Kinase | 1 | 1981 | 36 | 0.010 |
Why?
|
| Cyclooxygenase 2 | 1 | 2003 | 483 | 0.010 |
Why?
|
| Ascitic Fluid | 1 | 1981 | 76 | 0.010 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2002 | 334 | 0.010 |
Why?
|
| Immunochemistry | 1 | 2000 | 61 | 0.010 |
Why?
|
| Hypoxia | 1 | 2003 | 443 | 0.010 |
Why?
|
| RNA, Antisense | 1 | 2000 | 69 | 0.010 |
Why?
|
| Recombination, Genetic | 1 | 1982 | 613 | 0.010 |
Why?
|
| Mice, Inbred NZB | 1 | 1979 | 2 | 0.010 |
Why?
|
| Listeria monocytogenes | 1 | 1980 | 52 | 0.010 |
Why?
|
| Genetic Vectors | 2 | 1982 | 1694 | 0.010 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 1981 | 299 | 0.010 |
Why?
|
| RNA Stability | 1 | 2000 | 125 | 0.010 |
Why?
|
| Pulmonary Alveoli | 1 | 1981 | 208 | 0.010 |
Why?
|
| Colony-Stimulating Factors | 1 | 1979 | 82 | 0.010 |
Why?
|
| Deoxyribonucleases | 1 | 1979 | 46 | 0.010 |
Why?
|
| Bone Marrow Cells | 1 | 1983 | 943 | 0.010 |
Why?
|
| Risk Factors | 2 | 2006 | 17523 | 0.010 |
Why?
|
| Cell Aggregation | 1 | 1997 | 61 | 0.010 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 1997 | 189 | 0.010 |
Why?
|
| Chromosome Aberrations | 1 | 2005 | 1960 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2002 | 2063 | 0.010 |
Why?
|
| MutL Proteins | 1 | 1997 | 30 | 0.010 |
Why?
|
| Thioglycolates | 1 | 1976 | 7 | 0.010 |
Why?
|
| Mismatch Repair Endonuclease PMS2 | 1 | 1997 | 47 | 0.010 |
Why?
|
| Androgens | 1 | 2000 | 511 | 0.010 |
Why?
|
| RNA | 2 | 1997 | 1013 | 0.010 |
Why?
|
| MutS Homolog 2 Protein | 1 | 1997 | 178 | 0.010 |
Why?
|
| MutL Protein Homolog 1 | 1 | 1997 | 206 | 0.010 |
Why?
|
| Oxygen | 1 | 1981 | 754 | 0.010 |
Why?
|
| Gene Rearrangement | 2 | 1991 | 783 | 0.010 |
Why?
|
| Leukocytes | 1 | 1978 | 422 | 0.010 |
Why?
|
| Imidazoles | 1 | 2002 | 999 | 0.010 |
Why?
|
| Shigella | 1 | 1975 | 5 | 0.010 |
Why?
|
| Anticoagulants | 1 | 2002 | 787 | 0.010 |
Why?
|
| Stimulation, Chemical | 1 | 1975 | 97 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2008 | 4549 | 0.010 |
Why?
|
| Biodegradation, Environmental | 1 | 1975 | 19 | 0.010 |
Why?
|
| Serum Albumin | 1 | 1976 | 257 | 0.010 |
Why?
|
| Chromosome Deletion | 2 | 1991 | 1005 | 0.010 |
Why?
|
| Antibody Formation | 1 | 1976 | 383 | 0.010 |
Why?
|
| Iodine Radioisotopes | 2 | 1992 | 371 | 0.010 |
Why?
|
| Biological Transport | 1 | 1976 | 597 | 0.010 |
Why?
|
| Biomarkers | 1 | 2007 | 5047 | 0.010 |
Why?
|
| Thy-1 Antigens | 1 | 1985 | 51 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 1985 | 191 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2004 | 4744 | 0.010 |
Why?
|
| Cytomegalovirus | 2 | 1988 | 482 | 0.010 |
Why?
|
| Endocytosis | 1 | 1975 | 225 | 0.010 |
Why?
|
| 2',5'-Oligoadenylate Synthetase | 1 | 1994 | 19 | 0.010 |
Why?
|
| Receptor, Interferon alpha-beta | 1 | 1994 | 23 | 0.010 |
Why?
|
| Survival Rate | 1 | 2007 | 12221 | 0.010 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 1991 | 1331 | 0.010 |
Why?
|
| Kinetics | 1 | 1976 | 2049 | 0.010 |
Why?
|
| Species Specificity | 1 | 1985 | 777 | 0.010 |
Why?
|
| Drug Carriers | 1 | 1994 | 327 | 0.010 |
Why?
|
| Disulfides | 1 | 1992 | 116 | 0.010 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 1992 | 212 | 0.010 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1992 | 261 | 0.010 |
Why?
|
| Pancreatic Neoplasms | 1 | 1989 | 5061 | 0.010 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1992 | 362 | 0.010 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 1991 | 239 | 0.010 |
Why?
|
| Protein Conformation | 1 | 1985 | 1258 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1992 | 548 | 0.010 |
Why?
|
| Leukemia, Myeloid, Accelerated Phase | 1 | 1991 | 111 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 1997 | 1439 | 0.010 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 1990 | 78 | 0.010 |
Why?
|
| Histocompatibility Antigen H-2D | 1 | 1989 | 5 | 0.010 |
Why?
|
| Introns | 1 | 1991 | 432 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 1989 | 264 | 0.010 |
Why?
|
| Karyotyping | 1 | 1991 | 1022 | 0.010 |
Why?
|
| Complement System Proteins | 1 | 1989 | 139 | 0.010 |
Why?
|
| Cyclic GMP | 2 | 1979 | 116 | 0.010 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 1991 | 2796 | 0.000 |
Why?
|
| Philadelphia Chromosome | 1 | 1991 | 793 | 0.000 |
Why?
|
| Leukemia, Myeloid, Acute | 2 | 1991 | 6915 | 0.000 |
Why?
|
| Peptide Fragments | 1 | 1992 | 1271 | 0.000 |
Why?
|
| Leukemia, Myeloid, Chronic-Phase | 1 | 1991 | 505 | 0.000 |
Why?
|
| Acute Disease | 1 | 1991 | 2422 | 0.000 |
Why?
|
| Spleen | 1 | 1988 | 676 | 0.000 |
Why?
|
| Oncogene Protein pp60(v-src) | 1 | 1984 | 17 | 0.000 |
Why?
|
| Poly A | 1 | 1985 | 87 | 0.000 |
Why?
|
| Epidermal Growth Factor | 1 | 1984 | 423 | 0.000 |
Why?
|
| Genes, Viral | 1 | 1982 | 202 | 0.000 |
Why?
|
| Simplexvirus | 1 | 1982 | 159 | 0.000 |
Why?
|
| Receptors, Fc | 1 | 1981 | 69 | 0.000 |
Why?
|
| Placebos | 1 | 1980 | 437 | 0.000 |
Why?
|
| Theophylline | 1 | 1979 | 34 | 0.000 |
Why?
|
| Ethylenediamines | 1 | 1979 | 21 | 0.000 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 1979 | 66 | 0.000 |
Why?
|
| Epidermis | 1 | 1979 | 188 | 0.000 |
Why?
|
| Hydroxyurea | 1 | 1979 | 204 | 0.000 |
Why?
|
| Bone Marrow Transplantation | 1 | 1982 | 1581 | 0.000 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 1984 | 5437 | 0.000 |
Why?
|